Associated Papers
P2Y12 Polymorphisms and the Risk of Adverse Clinical Events in Patients Treated with Clopidogrel: A Meta-Analysis.
Zhao K et al.
Drug Research, 2019
Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention.
Sionova M et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology, 2017
High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial.
Motovska Z et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis, 2009
Select a paper to view details